Ma Yuefang, Pitson Stuart, Hercus Timothy, Murphy Jane, Lopez Angel, Woodcock Joanna
Cytokine Receptor Laboratory, Division of Human Immunology, Hanson Institute, G.P.O. Box 14 Rundle Mall, Adelaide SA 5000, Australia.
J Biol Chem. 2005 Jul 15;280(28):26011-7. doi: 10.1074/jbc.M409081200. Epub 2005 May 9.
Protein kinase A (PKA) has long been recognized as playing a major role in many regulatory processes in cells through its activation by the ubiquitous second messenger cAMP. We show here a novel mode of activation of PKA type II that is independent of cAMP and is, instead, dependent on sphingosine. PKA type II is specifically activated by sphingosine and its analog, dimethylsphingosine, but not by sphingosine-1-phosphate or other lipids. Like cAMP, sphingosine activates PKA holoenzyme but not the catalytic subunit alone, suggesting that the activation is mediated by the regulatory subunits. However, sphingosine-activated PKA, but not cAMP-activated PKA, is inhibited by phosphatidylserine, suggesting a distinct mechanism of activation. Furthermore, unlike cAMP, sphingosine does not induce the dissociation of PKA holoenzyme into catalytic and regulatory subunits. Modulation of sphingosine levels in vivo results in alteration in basal membrane-associated PKA activity consistent with a direct effect of membrane sphingosine on PKA type II. Importantly, sphingosine-dependent but not cAMP-dependent activation of PKA specifically phosphorylates Ser58 of the multifunctional adapter protein 14-3-3zeta, promoting the conversion of dimeric 14-3-3 to a monomeric state, thus potentially modulating several biological functions. These results define a new mode of PKA activation that is sphingosine-dependent and mechanistically different from the classical cAMP-dependent activation of PKA. Furthermore, they suggest that stimuli that induce sphingosine accumulation and modulate phospholipid content at the cell membrane have the potential to activate PKA, thereby inducing the phosphorylation of distinct substrates and biological activities.
蛋白激酶A(PKA)长期以来被认为通过其被普遍存在的第二信使环磷酸腺苷(cAMP)激活,在细胞的许多调节过程中发挥主要作用。我们在此展示了一种新型的II型PKA激活模式,该模式独立于cAMP,而是依赖于鞘氨醇。II型PKA被鞘氨醇及其类似物二甲基鞘氨醇特异性激活,但不被鞘氨醇-1-磷酸或其他脂质激活。与cAMP一样,鞘氨醇激活PKA全酶,但不单独激活催化亚基,这表明激活是由调节亚基介导的。然而,鞘氨醇激活的PKA,而不是cAMP激活的PKA,被磷脂酰丝氨酸抑制,这表明存在一种独特的激活机制。此外,与cAMP不同,鞘氨醇不会诱导PKA全酶解离为催化亚基和调节亚基。体内鞘氨醇水平的调节导致基底膜相关PKA活性的改变,这与膜鞘氨醇对II型PKA的直接作用一致。重要的是,PKA的鞘氨醇依赖性而非cAMP依赖性激活特异性地磷酸化多功能衔接蛋白14-3-3ζ的Ser58,促进二聚体14-3-3转化为单体状态,从而潜在地调节多种生物学功能。这些结果定义了一种新的PKA激活模式,该模式依赖于鞘氨醇,并且在机制上不同于PKA的经典cAMP依赖性激活。此外,它们表明诱导鞘氨醇积累并调节细胞膜磷脂含量的刺激有可能激活PKA,从而诱导不同底物的磷酸化和生物学活性。